Cassandra Rae Duffy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delivery, Obstetric | 8 | 2021 | 904 | 1.440 |
Why?
|
| Endometritis | 2 | 2020 | 48 | 0.910 |
Why?
|
| Povidone-Iodine | 2 | 2020 | 59 | 0.890 |
Why?
|
| Antibiotic Prophylaxis | 4 | 2020 | 638 | 0.850 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 128 | 0.700 |
Why?
|
| Clindamycin | 1 | 2020 | 139 | 0.690 |
Why?
|
| Gentamicins | 1 | 2020 | 253 | 0.660 |
Why?
|
| Lymphopenia | 1 | 2020 | 285 | 0.630 |
Why?
|
| Vagina | 2 | 2019 | 825 | 0.590 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2019 | 250 | 0.570 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 238 | 0.560 |
Why?
|
| Methadone | 1 | 2018 | 306 | 0.550 |
Why?
|
| Streptococcal Infections | 1 | 2020 | 637 | 0.530 |
Why?
|
| Obstetrics | 2 | 2019 | 657 | 0.510 |
Why?
|
| Standard of Care | 1 | 2019 | 562 | 0.510 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2019 | 501 | 0.490 |
Why?
|
| Cesarean Section | 2 | 2019 | 1363 | 0.460 |
Why?
|
| Clostridium Infections | 1 | 2020 | 548 | 0.440 |
Why?
|
| Tocolytic Agents | 1 | 2012 | 25 | 0.430 |
Why?
|
| Fetal Monitoring | 1 | 2012 | 70 | 0.420 |
Why?
|
| Pregnancy | 15 | 2022 | 29087 | 0.420 |
Why?
|
| Magnesium Sulfate | 1 | 2012 | 68 | 0.420 |
Why?
|
| Heart Rate, Fetal | 1 | 2012 | 75 | 0.420 |
Why?
|
| Buprenorphine | 1 | 2018 | 640 | 0.370 |
Why?
|
| Pregnancy Outcome | 2 | 2018 | 2795 | 0.370 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2020 | 2026 | 0.360 |
Why?
|
| Preoperative Care | 1 | 2019 | 2245 | 0.360 |
Why?
|
| Premature Birth | 1 | 2021 | 1713 | 0.350 |
Why?
|
| Labor, Obstetric | 1 | 2012 | 333 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 7153 | 0.300 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1967 | 0.290 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 1668 | 0.280 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 3667 | 0.260 |
Why?
|
| Maternal Exposure | 1 | 2012 | 961 | 0.260 |
Why?
|
| Hospitalization | 6 | 2020 | 10232 | 0.230 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
| Chorion | 1 | 2021 | 117 | 0.200 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 1538 | 0.180 |
Why?
|
| Placenta, Retained | 1 | 2019 | 21 | 0.180 |
Why?
|
| Uterine Balloon Tamponade | 1 | 2019 | 42 | 0.170 |
Why?
|
| Labor Presentation | 1 | 2018 | 53 | 0.160 |
Why?
|
| Chlorhexidine | 1 | 2020 | 162 | 0.160 |
Why?
|
| Perineum | 1 | 2019 | 211 | 0.160 |
Why?
|
| Term Birth | 1 | 2018 | 135 | 0.160 |
Why?
|
| Streptococcus agalactiae | 1 | 2020 | 375 | 0.160 |
Why?
|
| Lacerations | 1 | 2019 | 144 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 792 | 0.160 |
Why?
|
| Azithromycin | 1 | 2019 | 195 | 0.150 |
Why?
|
| Vancomycin | 1 | 2020 | 500 | 0.140 |
Why?
|
| Drug Utilization | 2 | 2019 | 1181 | 0.140 |
Why?
|
| Female | 15 | 2022 | 379592 | 0.130 |
Why?
|
| Opiate Substitution Treatment | 1 | 2018 | 404 | 0.120 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2022 | 1872 | 0.110 |
Why?
|
| Gestational Age | 1 | 2021 | 3490 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
| Gynecological Examination | 1 | 2012 | 33 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2022 | 25575 | 0.100 |
Why?
|
| Young Adult | 6 | 2020 | 56350 | 0.090 |
Why?
|
| Income | 1 | 2018 | 1904 | 0.090 |
Why?
|
| Humans | 15 | 2022 | 742088 | 0.090 |
Why?
|
| Linear Models | 1 | 2020 | 5948 | 0.090 |
Why?
|
| Adolescent | 6 | 2020 | 85649 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2020 | 7716 | 0.080 |
Why?
|
| Developing Countries | 1 | 2018 | 2789 | 0.070 |
Why?
|
| Adult | 7 | 2020 | 213712 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7770 | 0.060 |
Why?
|
| Fever | 1 | 2012 | 1612 | 0.060 |
Why?
|
| Pain | 1 | 2019 | 4961 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3306 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1196 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 24913 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19862 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2022 | 644 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
| Codeine | 1 | 2019 | 49 | 0.040 |
Why?
|
| Tramadol | 1 | 2019 | 50 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2022 | 566 | 0.040 |
Why?
|
| Anal Canal | 1 | 2019 | 376 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15244 | 0.040 |
Why?
|
| HIV Infections | 1 | 2022 | 16678 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 53187 | 0.030 |
Why?
|
| United States | 2 | 2020 | 69693 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1600 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15530 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 72145 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2012 | 591 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2012 | 77098 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2019 | 2493 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 213127 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 62966 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 2062 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 35070 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9679 | 0.010 |
Why?
|